GlassScriptPhysician profile
Nicole Yoder Rose
NPI 1881116093
$2,039.23
in general payments reported to CMS, 2019-2025
17 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $142 · 2021: $67.03 · 2022: $580 · 2023: $502 · 2024: $157 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $370.03 | 2022-2025 | Total30, Precision7, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $265.09 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $242.99 | 2023-2025 | Infuse, Vyzulta, Miebo |
| Coopervision INC. | $171.17 | 2023-2025 | Myday Contact Lens, Misight Contact Lens |
| Biotissue Holdings INC. | $132.39 | 2022 | |
| Sun Pharmaceutical Industries INC. | $126.64 | 2019-2023 | Cequa |
| Aerie Pharmaceuticals, INC. | $116.07 | 2019 | |
| Oyster Point Pharma, INC. | $113.30 | 2022 | |
| Maculogix, INC. | $102.58 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.71 | 2019-2021 | |
| Horizon Therapeutics Plc | $79.80 | 2023 | Tepezza |
| Shire North American Group INC | $65.96 | 2019 | |
| Harrow Eye, LLC | $64.53 | 2025 | Vevye |
| Abbvie INC. | $31.88 | 2025 | |
| Novartis Pharmaceuticals Corporation | $23.94 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $16.38 | 2019 | |
| Eyevance Pharmaceuticals LLC | $15.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.